- Home
- CLNN vs OMIC Comparison
CLNN vs OMIC Comparison
Compare CLNN & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- OMIC
- Stock Information
- Founded
- CLNN 2012
- OMIC 2016
- Country
- CLNN United States
- OMIC United States
- Employees
- CLNN N/A
- OMIC N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- OMIC Medical/Dental Instruments
- Sector
- CLNN Health Care
- OMIC Health Care
- Exchange
- CLNN Nasdaq
- OMIC Nasdaq
- Market Cap
- CLNN 43.0M
- OMIC 49.9M
- IPO Year
- CLNN N/A
- OMIC 2021
- Fundamental
- Price
- CLNN $4.68
- OMIC $19.89
- Analyst Decision
- CLNN Strong Buy
- OMIC Hold
- Analyst Count
- CLNN 4
- OMIC 2
- Target Price
- CLNN $55.25
- OMIC $10.75
- AVG Volume (30 Days)
- CLNN 69.1K
- OMIC 21.3K
- Earning Date
- CLNN 03-12-2025
- OMIC 03-17-2025
- Dividend Yield
- CLNN N/A
- OMIC N/A
- EPS Growth
- CLNN N/A
- OMIC N/A
- EPS
- CLNN N/A
- OMIC N/A
- Revenue
- CLNN $421,000.00
- OMIC $2,667,000.00
- Revenue This Year
- CLNN N/A
- OMIC $0.82
- Revenue Next Year
- CLNN N/A
- OMIC $252.64
- P/E Ratio
- CLNN N/A
- OMIC N/A
- Revenue Growth
- CLNN N/A
- OMIC 2.77
- 52 Week Low
- CLNN $3.82
- OMIC $5.34
- 52 Week High
- CLNN $11.00
- OMIC $23.41
- Technical
- Relative Strength Index (RSI)
- CLNN 44.03
- OMIC 52.60
- Support Level
- CLNN $4.75
- OMIC $19.67
- Resistance Level
- CLNN $5.06
- OMIC $19.90
- Average True Range (ATR)
- CLNN 0.37
- OMIC 0.26
- MACD
- CLNN -0.07
- OMIC 0.03
- Stochastic Oscillator
- CLNN 3.59
- OMIC 85.33
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.